The Economic Corner || Should The Governments Work With A Portfolio Of Vaccines To End The Pandemic?

Welcome to the Economic Corner – where we update you on all the biggest global economic announcements. 

• First up on the Economic Corner is a major update coming in from the Downing Street. British Prime Minister Boris Johnson and Australian Prime Minister Scott Morrison agreed on broad terms of a trade deal over dinner. This is the first trade deal to be negotiated from scratch since the UK left the EU.

• The UK government said that membership of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) could provide British farmers with huge opportunities.

• Moving on to the Minutes of the Monetary Policy Meeting of the Reserve Bank Board --- Members started their discussion of international economic developments by noting that the global outlook had improved over recent months and risks to the global economy had become more balanced.

• COVID-19 case numbers had fallen in many advanced economies as vaccination rates had risen, and containment measures were being eased.

•  Turning to domestic economic developments, members noted that the Australian economy was transitioning from recovery to expansion with more momentum than previously anticipated.

• The European Union is testing investors’ appetite to fund nearly $1 trillion of debt over five years as it seeks to finance its recovery from the coronavirus pandemic.

• Next up is a good news on the vaccine efficiency front -- Novavax’s Covid-19 vaccine remains effective when administered at the same time as a flu jab. The phase 3 trial was carried out on 431 people in the UK.


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK